Correlation of CT imaging features and tumor size with Fuhrman grade of clear cell renal cell carcinoma

2016 ◽  
Vol 58 (3) ◽  
pp. 376-384 ◽  
Author(s):  
Saelin Oh ◽  
Deuk Jae Sung ◽  
Kyung Sook Yang ◽  
Ki Choon Sim ◽  
Na Yeon Han ◽  
...  

Background Identification of clinical features to determine the aggressive potential of tumors is highly warranted to stratify patients for adequate treatment. Computed tomography (CT) imaging features of clear cell renal cell carcinoma (ccRCC) may contribute to personalized risk assessment. Purpose To assess the correlation between CT imaging features and Fuhrman grade of ccRCC, and to identify the predictors of high Fuhrman grade in conjunction with tumor size. Material and Methods CT scans of 169 patients with 173 pathologically proven ccRCCs were retrospectively reviewed in consensus by two radiologists for the presence of intratumoral necrosis and intratumoral cyst and tumor size. Histologic grade was classified as either low (Fuhrman grade I or II) or high (Fuhrman grade III or IV). Statistical significance was evaluated by using univariate, multivariate regression, receiver operating characteristic (ROC) curve, and Spearman correlation analyses. Results On CT, 20 of the 173 tumors had intratumoral cysts, 60 had intratumoral necrosis, and 93 showed entirely solid tumors. The odds of high grade were higher with intratumoral necrosis and entirely solid tumor than with intratumoral cyst ( P < 0.03). Intratumoral necrosis showed a significantly high odds ratio of 25.73 for high Fuhrman grade. The ROC curve showed a threshold tumor size of 36 mm to predict high Fuhrman grade for overall tumors (area under the ROC curve, 0.70). In ccRCCs with intratumoral necrosis or cyst, tumor size did not significantly correlate with Fuhrman grade. Conclusion Intratumoral necrosis on CT was a strong and independent predictor of biologically aggressive ccRCCs, irrespective of tumor size.

2014 ◽  
Vol 15 (18) ◽  
pp. 7821-7824 ◽  
Author(s):  
Emre Can Polat ◽  
Alper Otunctemur ◽  
Emin Ozbek ◽  
Huseyin Besiroglu ◽  
Murat Dursun ◽  
...  

Radiology ◽  
2011 ◽  
Vol 261 (3) ◽  
pp. 854-862 ◽  
Author(s):  
Steven C. Sauk ◽  
Margaret S. Hsu ◽  
Daniel J. A. Margolis ◽  
David S. K. Lu ◽  
Nagesh P. Rao ◽  
...  

Radiology ◽  
2014 ◽  
Vol 270 (2) ◽  
pp. 464-471 ◽  
Author(s):  
Christoph A. Karlo ◽  
Pier Luigi Di Paolo ◽  
Joshua Chaim ◽  
A Ari Hakimi ◽  
Irina Ostrovnaya ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jazmine Arévalo ◽  
David Lorente ◽  
Enrique Trilla ◽  
María Teresa Salcedo ◽  
Juan Morote ◽  
...  

AbstractClear cell renal cell carcinoma (ccRCC) is the most frequent and aggressive subtype of renal carcinoma. So far, the basis of its oncogenesis remains unclear resulting in a deficiency of usable and reliable biomarkers for its clinical management. Previously, we showed that nuclear expression of the signal transducer and activator of transcription 3 (STAT3), phosphorylated at its serine 727 (pS727), was inversely proportional to the overall survival of ccRCC patients. Therefore, in the present study, we validated the value of pS727-STAT3 as a clinically relevant biomarker in ccRCC. This work is a retrospective study on 82 ccRCC patients treated with nephrectomy and followed-up for 10 years. Immunohistochemical expression of pS727-STAT3 was analyzed on a tissue microarray and nuclear and cytosolic levels were correlated with clinical outcome of patients. Our results showed that pS727-STAT3 levels, whether in the nucleus (p = 0.002; 95% CI 1.004–1.026) or the cytosol (p = 0.040; 95% CI 1.003–1.042), significantly correlate with patients’ survival in an independent-manner of clinicopathological features (Fuhrman grade, risk group, and tumor size). Moreover, we report that patients with high pS727-STAT3 levels who undergone adjuvant therapy exhibited a significant stabilization of the disease (~ 20 months), indicating that pS727-STAT3 can pinpoint a subset of patients susceptible to respond well to treatment. In summary, we demonstrated that high pS727-STAT3 levels (regardless of their cellular location) correlate with low overall survival of ccRCC patients, and we suggested the use of pS727-STAT3 as a prognostic biomarker to select patients for adjuvant treatment to increase their survival.


2016 ◽  
Vol 35 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Antoni Vilaseca ◽  
Daniel P. Nguyen ◽  
Emily A. Vertosick ◽  
Renato B. Corradi ◽  
Mireia Musquera ◽  
...  

2015 ◽  
Vol 40 (8) ◽  
pp. 3168-3174 ◽  
Author(s):  
Hannu Huhdanpaa ◽  
Darryl Hwang ◽  
Steven Cen ◽  
Brian Quinn ◽  
Megha Nayyar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document